Similar content being viewed by others Introduction Glucagon-like-peptide-1 (GLP-1) is a metabolic hormone secreted by intestinal endocrine L-cells and stimulates insulin secretion in a glucose-dependent manner [1]
When considering 2028, people are scratching their heads, saying: What will I do then? In the meantime, physicians such as Moore and Weber hope the program will allow more patients to start taking a GLP-1
For example, a researcher maintaining at 8mg who has plateaued might increase to 10mg for 3 weeks, then return to 8mg
PMID: 30 JinT
Last reviewed: June 8, 2026 Last updated: June 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
While we strive to keep our content current with the latest research and clinical guidelines, it is intended for general informational purposes only